Catalyst Wire Dossier Catalyst Wire Dossier

Glaritus

insulin glargine · Wockhardt
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glaritus, covering 2013-01-25 to 2013-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM [Phase 1]

See pricing